Published in

BioMed Central, BMC Cancer, 1(18), 2018

DOI: 10.1186/s12885-018-5167-y

Links

Tools

Export citation

Search in Google Scholar

Discontinuation of tyrosine kinase inhibitors in CML patients in real-world clinical practice at a single institution

This paper is made freely available by the publisher.
This paper is made freely available by the publisher.

Full text: Download

Green circle
Preprint: archiving allowed
Green circle
Postprint: archiving allowed
Green circle
Published version: archiving allowed
Data provided by SHERPA/RoMEO